Back

Warfarin vs novel oral anticoagulants post-Watchman implantation: post FDA approval single-center U.S. Watchman implantation experience

30 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Non-coronary cardiac interventions and more Non coronary cardiac interventions ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Yoshinari Enomoto

National Center for Global Health and Medicine, Tokyo (Japan)

19 More presentations in this session

Presentation thumbnail
Doctor K. Alassas (Awali, BH)
Presentation thumbnail
Miss C. Marzahn (Bernau bei Berlin, DE)
Abstract
Presentation thumbnail
Associate Professor Z. Dimitriadis (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Associate Professor B. Luani (Ingolstadt, DE)
Abstract Slides
Presentation thumbnail
Doctor J. Yu (Koblenz, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Non-coronary cardiac interventions and more

The Event

Event poster

ESC Congress 2016

30 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prevention of thromboembolic events in atrial fibrillation patients with persistent leaks following the watchman implantation
31 August 2024
thumbnail
Congress Presentation
Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
2 September 2019
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022
thumbnail
Congress Presentation
Left atrial appendage closure in atrial fibrillation: gaps in knowledge
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources